高等学校化学学报

• 研究论文 • 上一篇    下一篇

含硫肽结构的噻肟酰胺衍生物的设计、合成与抗菌活性

佘慧娴,陈阳密,杨家强   

  1. 遵义医科大学药学院
  • 收稿日期:2024-12-18 修回日期:2025-02-17 出版日期:2025-02-20 发布日期:2025-02-20
  • 通讯作者: 杨家强 E-mail:yjqcn@126.com
  • 基金资助:
    贵州省科技计划项目(批准号:黔科合基础-ZK[2024]一般265)和国家级大学生创新创业训练计划项目(批准号:202310661006)资助

Design, Synthesis and Antibacterial Activities of Thioxime Amide Derivatives Containing Thiopeptide

SHE Huixian, CHEN Yangmi, YANG Jiaqiang   

  1. School of Pharmacy, Zunyi Medical University
  • Received:2024-12-18 Revised:2025-02-17 Online:2025-02-20 Published:2025-02-20
  • Contact: YANG Jiaqiang E-mail:yjqcn@126.com
  • Supported by:
    Supported by the Guizhou Provincial Science and Technology Plan Project of China(No. Qiankehe Foundation ZK[2024]265) and the National College Students' innovation and entrepreneurship training program(No. 202310661006)

摘要: 为了获取新型抗菌活性化合物,运用药效团拼合原理,将氨基噻唑、肟和硫肽结构通过酰胺键组合,设计合成了24个含硫肽结构的噻肟酰胺衍生物,经核磁共振波谱((1H NMR, 13C NMR)和元素分析确证其结构。活性测试结果表明,该类衍生物对革兰氏阳性菌有较显著活性,目标化合物5u对金黄色葡萄球菌(S. aureus)和耐甲氧西林金黄色葡萄球菌(MRSA)的最小抑菌浓度(MIC)分别为0.25 μg/mL和2 μg/mL,5v对S. aureus和MRSA的MIC分别为0.5 μg/mL和2 μg/mL,其抗S. aureus活性优于对照药苯唑西林(MIC=0.5 μg/mL)或与之相对,抗MRSA活性显著,远优于对照药苯唑西林(MIC>128 μg/mL),可作为抗菌候选化合物进行深入研究。

关键词: 硫肽, 噻肟酰胺衍生物, 药物设计, 合成, 抗菌活性

Abstract: In order to obtain novel antibacterial compounds, using the principle of pharmacophore assembly, twenty-four novel thioxime amide derivatives containing thiopeptide were designed and synthesized by combining active fragments of amino thiazole, oxime and thiopeptides, and confirmed by means of nuclear magnetic resonance hydrogen spectroscopy(1H NMR), nuclear magnetic resonance carbon spectroscopy(13C NMR) and elemental analysis. The antibacterial activities test results showed that these derivatives have significant activity against Gram positive bacteria. the minimum inhibitory concentration(MIC) values of compound 5u against S. aureus and methicillin-resistant S. aureus(MRSA) were 0.25 μg/mL and 2 μg/mL respectively, the MIC values of 5v against S. aureus and MRSA were 0.5 μg/mL and 2 μg/mL, respectively. Its anti- S. aureus activity was superior to that of the control drug oxacillin(MIC=0.5 μg/mL) or relatively, and its anti-MRSA activity was significantly better than that of the control drug(MIC>128 μg/mL), which will be further developed as novel candidates for antibacterial drugs.

Key words: Thiopeptide; Thioxime amide derivatives, Drug design, Synthesis, Antibacterial activity

中图分类号: 

TrendMD: